// App-Quantinova.ai

: Effects of double dose alpha 1 antitrypsin (AAT) therapy on cytokine pathways in AAT Deficiency (AATD)

Researchers

Presenter

  • Michael Campos

Principal Investigators

  • Patrick Geraghty

  • Gregory Holt

  • Elio Donna

  • Eliana Mendes

  • Luis Escobar

  • Landy Luna

  • Robert Stockley

Medical Centers

  • University of Miami - Miami - United States of America

  • SUNY Downstate Medical Center - Brooklyn - United States of America

  • University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Gastroenterology (GU)

  • Pulmonary/Respiratory Diseases

Disease

  • Alpha-1 antitrypsin (A1AT) deficiency

Biomarkers

  • Alpha-1 antitrypsin

Drug/Treatment

  • Alpha 1-Antitrypsin

  • Zemaira

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved